AstraZeneca Plc has agreed to a $26 million settlement with the state of South Carolina to settle a lawsuit accusing it of misleading consumers about the risks associated with taking the anti-psychotic drug Seroquel.Read More »
Health insurance plans cannot sue a pharmaceutical company to recover the cost of prescriptions written for the “off-label” use of its anti-psychotic drug, the 11th Circuit has ruled in affirming dismissals.Read More »
Much like 2009, 2010 was a busy year for prescription drug suits.
Tagged with: Accutane Allergan antidepressant Avandia AztraZeneca Botox Botox litigation Department of Justice DOJ epilepsy failure to warn GlaxoSmithKline heart attack hormone replacement therapy hormone replacement therapy litigation Johnson & Johnson Levaquin Neurontin Paxil Pfizer Premarin Prempro Provera Roche Seroquel WyethRead More »
Pharmaceutical company AstraZeneca will pay about $198 million to settle over 17,000 lawsuits filed by plaintiffs who developed diabetes after taking the atypical antipsychotic drug Seroquel, used to treat schizophrenia and bipolar disorders.Read More »
Utah’s attorney general has filed suit against Johnson & Johnson and AstraZeneca for allegedly illegal off-label marketing of anti-psychotic drugs.Read More »
AstraZeneca has agreed to pay the U.S. government $520 million to settle charges that it illegally promoted its anti-psychotic drug Seroquel for off-label uses that were not approved by the Food and Drug Administration.Read More »